Lymph Node Biopsy Recommendations

Indications for Biopsy

The presence of a fatty hilum cannot definitively rule out malignancy, particularly early-stage lymphoma, with 86-93% sensitivity for excluding metastatic disease 1
Up to 25% of clinically negative lymph nodes harbor micrometastases, making imaging features alone insufficient to exclude malignancy 1
Lymph nodes exceeding 15 mm in short axis require escalation to further workup, regardless of other features, due to increased malignancy risk 2
Heterogeneous cortex is a concerning feature that warrants biopsy, as cortical thickness >3 mm carries increased malignancy risk 2
The combination of size exceeding thresholds plus cortical heterogeneity creates sufficient concern that observation alone is inadequate 1

US-guided fine-needle aspiration biopsy (US-FNAB) is the recommended first-line diagnostic method, with 80-93% sensitivity and approaching 100% specificity 1
In cases where US-FNAB is non-diagnostic or shows atypical features, core needle biopsy should be performed 1
Excisional biopsy should be performed if core biopsy remains inconclusive and clinical suspicion persists 1

Follicular lymphoma can demonstrate spontaneous regressions in up to 25% of cases, creating variable clinical courses that can be misleading 1
Aggressive lymphomas can present acutely, and early-stage follicular lymphoma may have preserved nodal architecture initially, making imaging unreliable for exclusion 1
A family history of cancer in an asymptomatic patient should lower the threshold for tissue diagnosis, as hereditary cancer syndromes may present with atypical nodal features 1

Hypervascularity with peripheral vascularization can be a suspicious feature in some contexts, such as vulvar cancer staging 3, 4
The absence of a fatty hilum has 90-93% positive predictive value for malignancy, but its presence does not guarantee benignity when other red flags exist 1, 2
Asymptomatic presentation does not exclude malignancy, and waiting for symptoms to develop before pursuing tissue diagnosis may allow progression from early to advanced disease 1